Published in Sci Rep on October 06, 2016
Vascular biology of hydrogen sulfide. Am J Physiol Cell Physiol (2017) 0.77
Reciprocal regulation of eNOS, H2S and CO-synthesizing enzymes in human atheroma: Correlation with plaque stability and effects of simvastatin. Redox Biol (2017) 0.75
H2S regulates endothelial nitric oxide synthase protein stability by promoting microRNA-455-3p expression. Sci Rep (2017) 0.75
International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors. Pharmacol Rev (2017) 0.75
Atherosclerosis. the road ahead. Cell (2001) 11.88
The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J (2001) 7.97
H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science (2008) 7.89
Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J (2002) 6.89
HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol (1992) 6.50
Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol (2005) 4.29
The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res (2007) 3.15
Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res (2009) 2.83
Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation (2008) 2.74
Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci U S A (2009) 2.66
Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation (2006) 2.53
Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation (2004) 2.30
Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol (2008) 2.29
Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther (2005) 1.96
Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer. Clin Chem (1986) 1.92
Critical cap thickness and rupture in symptomatic carotid plaques: the oxford plaque study. Stroke (2008) 1.80
Hydrogen sulphide and angiogenesis: mechanisms and applications. Br J Pharmacol (2011) 1.63
Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J Vasc Surg (1999) 1.62
Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation (2010) 1.61
Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest (2008) 1.49
Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells. Cardiovasc Res (2010) 1.31
Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis. Circulation (2013) 1.26
VEGFR2 functions as an H2S-targeting receptor protein kinase with its novel Cys1045-Cys1024 disulfide bond serving as a specific molecular switch for hydrogen sulfide actions in vascular endothelial cells. Antioxid Redox Signal (2013) 1.16
Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. J Am Soc Nephrol (2013) 1.16
Carotid plaque formation and serum biomarkers. Atherosclerosis (2010) 1.11
The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice. Br J Pharmacol (2013) 1.02
Hydrogen sulfide and the pathogenesis of atherosclerosis. Antioxid Redox Signal (2013) 1.01
Characterisation of cystathionine gamma-lyase/hydrogen sulphide pathway in ischaemia/reperfusion injury of the mouse kidney: an in vivo study. Eur J Pharmacol (2009) 0.98
Increased neointimal formation in cystathionine gamma-lyase deficient mice: role of hydrogen sulfide in α5β1-integrin and matrix metalloproteinase-2 expression in smooth muscle cells. J Mol Cell Cardiol (2011) 0.95
RNA damage in human atherosclerosis: pathophysiological significance and implications for gene expression studies. RNA Biol (2005) 0.88
Biological mechanisms of microvessel formation in advanced atherosclerosis: the big five. Trends Cardiovasc Med (2013) 0.85
Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis--implications for cardiovascular safety. Int J Cardiol (2013) 0.85
Anti-atherogenic effect of hydrogen sulfide by over-expression of cystathionine gamma-lyase (CSE) gene. PLoS One (2014) 0.83
Regulation of cystathionine γ-lyase in mammalian cells by hypoxia. Biochem Genet (2013) 0.83
Cystathionine γ-lyase regulates arteriogenesis through NO-dependent monocyte recruitment. Cardiovasc Res (2015) 0.83
Gene delivery of soluble vascular endothelial growth factor receptor-1 (sFlt-1) inhibits intra-plaque angiogenesis and suppresses development of atherosclerotic plaque. Clin Exp Med (2010) 0.82
Hydrogen sulfide promotes angiogenesis by downregulating miR-640 via the VEGFR2/mTOR pathway. Am J Physiol Cell Physiol (2015) 0.78